253 related articles for article (PubMed ID: 10588093)
21. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
McGill JB; Reilly PA
Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
[TBL] [Abstract][Full Text] [Related]
22. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.
Weir MR; Elkins M; Liss C; Vrecenak AJ; Barr E; Edelman JM
Clin Ther; 1996; 18(3):411-28. PubMed ID: 8829017
[TBL] [Abstract][Full Text] [Related]
23. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
Weisser B; Gerwe M; Braun M; Funken C
Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
[TBL] [Abstract][Full Text] [Related]
24. Clinical profile of the novel angiotensin II type I blocker candesartan cilexetil.
Sever PS
J Hypertens Suppl; 1997 Dec; 15(6):S9-12. PubMed ID: 9493121
[TBL] [Abstract][Full Text] [Related]
25. Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial Investigators.
Manolis AJ; Grossman E; Jelakovic B; Jacovides A; Bernhardi DC; Cabrera WJ; Watanabe LA; Barragan J; Matadamas N; Mendiola A; Woo KS; Zhu JR; Mejia AD; Bunt T; Dumortier T; Smith RD
Clin Ther; 2000 Oct; 22(10):1186-203. PubMed ID: 11110230
[TBL] [Abstract][Full Text] [Related]
26. Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.
Oparil S; Barr E; Elkins M; Liss C; Vrecenak A; Edelman J
Clin Ther; 1996; 18(4):608-25. PubMed ID: 8879890
[TBL] [Abstract][Full Text] [Related]
27. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR
Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591
[TBL] [Abstract][Full Text] [Related]
28. The effects of irbesartan added to hydrochlorothiazide for the treatment of hypertension in patients non-responsive to hydrochlorothiazide alone.
Rosenstock J; Rossi L; Lin CS; MacNeil D; Osbakken M
J Clin Pharm Ther; 1998 Dec; 23(6):433-40. PubMed ID: 10048504
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension.
Townsend R; Haggert B; Liss C; Edelman JM
Clin Ther; 1995; 17(5):911-23. PubMed ID: 8595643
[TBL] [Abstract][Full Text] [Related]
30. Candesartan cilexetil: a new, long-acting, effective angiotensin II type 1 receptor blocker.
Sever P
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S91-5. PubMed ID: 9331018
[TBL] [Abstract][Full Text] [Related]
31. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring.
Baguet JP; Nisse-Durgeat S; Mouret S; Asmar R; Mallion JM
Int J Clin Pract; 2006 Apr; 60(4):391-8. PubMed ID: 16620350
[TBL] [Abstract][Full Text] [Related]
32. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
Lacourcière Y; Asmar R
Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
[TBL] [Abstract][Full Text] [Related]
33. Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility.
Mengden T; Uen S; Bramlage P
Vasc Health Risk Manag; 2009; 5():1043-58. PubMed ID: 20057897
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and tolerability of a combination tablet of candesartan cilexetil and hydrochlorothiazide in insufficiently controlled primary hypertension--comparison with a combination of losartan and hydrochlorothiazide.
Ohma KP; Milon H; Valnes K
Blood Press; 2000; 9(4):214-20. PubMed ID: 11055474
[TBL] [Abstract][Full Text] [Related]
35. Effects of candesartan cilexetil on health-related quality of life in black patients with systemic hypertension in the ABC Trial.
Zyczynski TM; Leidy NK; Kong BW; Helaszek CT; Michelson EL;
Heart Dis; 2000; 2(6):400-6. PubMed ID: 11728290
[TBL] [Abstract][Full Text] [Related]
36. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].
Baumgart P; Reismann J; Pohlmeyer H; Düsing R
Dtsch Med Wochenschr; 2001 May; 126(19):547-50. PubMed ID: 11402910
[TBL] [Abstract][Full Text] [Related]
37. Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients.
Ruilope LM; Simpson RL; Toh J; Arcuri KE; Goldberg AI; Sweet CS
Blood Press; 1996 Jan; 5(1):32-40. PubMed ID: 8777471
[TBL] [Abstract][Full Text] [Related]
38. Switch from ABCD pretreatment to A-II-A treatment: a multinational, open, centrally randomized, prospective parallel group comparison.
Asmar R; Porcellati C; Dusing R
Drugs Exp Clin Res; 2004; 30(4):153-61. PubMed ID: 15553661
[TBL] [Abstract][Full Text] [Related]
39. A Combination of Candesartan Cilexetil/hydrochlorothiazide (HCTZ), 8/12.5 mg, has a Similar Antihypertensive Efficacy and is Better Tolerated than Lisinopril/HCTZ, 10/12.5 mg.
T McINNES G; Istad H; Keinänen-Kiukaanniemi S; VAN Mierlo HFCM
Blood Press; 2000; 9(sup1):61. PubMed ID: 28425809
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I-II essential hypertension: a randomized, double-blind clinical study.
Rakugi H; Enya K; Sugiura K; Ikeda Y
Hypertens Res; 2012 May; 35(5):552-8. PubMed ID: 22278628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]